# OnCo record anaplastic-thyroid-cancer (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/anaplastic-thyroid-cancer/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "anaplastic-thyroid-cancer" ;
  schema:name "Anaplastic thyroid cancer"@en ;
  schema:alternateName "Anaplastic thyroid carcinoma"@en, "ATC"@en, "Undifferentiated thyroid carcinoma"@en ;
  schema:description "Anaplastic thyroid cancer is the rare, fast-growing form that presents as a rapidly enlarging neck mass threatening the airway. It was almost uniformly fatal within months; combining BRAF-targeted drugs, immunotherapy, surgery and radiotherapy has lifted survival for the first time."@en ;
  schema:url <https://onco.cc/cancers/anaplastic-thyroid-cancer/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Anaplastic_thyroid_cancer> ;
  schema:citation <https://en.wikipedia.org/wiki/Anaplastic_thyroid_cancer> ;
  onco:tag "subtype-page" ;
  onco:related <https://onco.cc/cancers/follicular-thyroid-cancer/>, <https://onco.cc/cancers/medullary-thyroid-cancer/>, <https://onco.cc/cancers/papillary-thyroid-cancer/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-subbiah-dabrafenib-trametinib-atc-jco-2018/>, <https://onco.cc/key-papers/paper-ata-anaplastic-thyroid-guideline-bible-thyroid-2021/>, <https://onco.cc/key-papers/paper-maniakas-neoadjuvant-braf-atc-jama-oncol-2020/> ;
  onco:pipeline <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/lenvatinib/> ;
  onco:standardOfCare <https://onco.cc/targets/braf/>, <https://onco.cc/drugs/dabrafenib/>, <https://onco.cc/drugs/trametinib/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/lenvatinib/>, <https://onco.cc/technologies/palliative-radiotherapy/>, <https://onco.cc/technologies/palliative-care/> .